63224-32-8 Usage
Specific content
Chemical compound name
Specific content
Common name or alternative designation for the compound
Specific content
Group of chemicals that the compound belongs to
4. Antineoplastic activity
Specific content
Ability to inhibit the growth and spread of cancer cells
5. Immune modulating activity
Specific content
Capacity to regulate the immune system's response
Specific content
Enzyme involved in DNA synthesis that the compound can inhibit
Specific content
Process of programmed cell death in tumor cells induced by the compound
8. Anti-inflammatory properties
Specific content
Ability to reduce inflammation, which can help modulate the immune response
Specific content
Range of medical conditions for which the compound shows promise as a treatment
Specific content
Requirement for additional studies to fully understand the mechanisms of action and potential clinical applications of the compound
Chemical category
Hydrazine derivative
Target enzyme
Thymidylate synthase
Induced action
Tumor cell apoptosis
Therapeutic potential
Treatment of various cancers and inflammatory disorders
Research status
Further research needed
Check Digit Verification of cas no
The CAS Registry Mumber 63224-32-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,2,2 and 4 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 63224-32:
(7*6)+(6*3)+(5*2)+(4*2)+(3*4)+(2*3)+(1*2)=98
98 % 10 = 8
So 63224-32-8 is a valid CAS Registry Number.
63224-32-8Relevant articles and documents
Design, synthesis and antibacterial evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl] Ciprofloxacin-(4-Methyl-3-Aryl)-1,2,4-Triazole-5(4H)-Thione Hybrids
Geng, Yun-He,Wei, Zeng-Quan,Xu, Zhi,Na, Lu-Xin,Zhang, Shu,Guo, Hui-Yuan,Liu, Ming-Liang,Feng, Lian-Shun,You, Xue-Fu
, p. 101 - 107 (2019/08/01)
Fourteen novel 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxac in-(4-methyl-3-aryl)-1,2,4-triazole-5(4H)-thione hybrids 6a-n were designed, synthesized and assessed for their in vitro antibacterial activities against representative Gram-positive and Gram-negat